REG - Bank of NY Mel Corp Medtronic, Inc. - Form 8.3 - Medtronic Inc. <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

21/11/2014 08:26

RNS Number : 5981X
Bank of New York Mellon Corp. (The)
20 November 2014
Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
The Bank of New York Mellon Corporation and its subsidiaries; 1. The Bank of New York Mellon, 2. The Dreyfus Corporation, 3. BNY Mellon Service Kapitalanlage-Gesellschaft mbH, 4. Lockwood Advisors, Inc. 5. Mellon Capital Management Corporation, 6. BNY Mellon Trust Company (Cayman) Limited, 7. BNY Mellon Trust of Delaware, 8. BNY Mellon, National Association, 9. The Boston Company Asset Management LLC, 10. MBSC Securities Corporation, 11. BNY Mellon Capital Markets, LLC, 12. Newton Investment Management Limited, 13. Newton Capital Management Limited.
Companydealtin
Medtronic Inc
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
$0.10 Common Shares
Dateofdealing
19 November 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)

Long
Short

Number

(%)
Number

(%)
(1)Relevantsecurities
17,000,667 1.73%
55 0.00001%
(2)Derivatives(otherthanoptions)


(3)Optionsandagreementstopurchase/sell


Total
17,000,667 1.73%
55 0.00001%
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short

Number

(%)
Number

(%)
(1)Relevantsecurities


(2)Derivatives(otherthanoptions)


(3)Optionsandagreementstopurchase/sell


Total



Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase
Purchase
Sale
Sale
Sale
Transfer In
Purchase
Sale
50
38,678
38,828
410
542
205
2,434
16
USD 71.76
USD 71.95
USD 71.91
USD 71.77
USD 71.76
N/A
USD 72.35
USD 71.94
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)




(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)







(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)



(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)



Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalof
anyrelevant securitiestowhichanyderivativereferredtoonthisformisreferenced.
Ifnone,this shouldbestated.
 None
IsaSupplementalForm8attached?(Note9) NO
Dateofdisclosure
20 November 2014
Contactname
Andrew Weiser
Telephonenumber
1-516-338-3752
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected

IfaconnectedEFM,statenatureofconnection(Note10)


This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISELLFESLLLIFIS